BIO is the world’s largest advocacy association representing biotechnology companies, academic and research institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.
The Modular Training for the Bioprocess Industries (MBI) programme pioneered by UCL Biochemical Engineering is a series of intensive short modules designed for professionals in the bioprocessing industry. The MBI Programme has a long history of equipping the bioprocessing industry's workforce with up-to-date skills and knowledge of process options in order to rapidly develop validatable, efficient and robust processes.
Join us in Manchester on Thursday 25 June 2026 for the UK Human Functional Genomics Initiative Scientific Symposium.
Building on the momentum of the inaugural 2025 meeting at the University of Exeter, this symposium promises to deepen the conversation around how to translate genetic-variation into biological mechanism and, ultimately, human health impact.
Join drug discovery industry leaders exploring the latest advances in biologics discovery, AI, and high-throughput characterization from AVSBio, AstraZeneca, Cradle, GSK, University of Oxford, and Carterra. Free to attend!
Stevenage Bioscience Catalyst invites colleagues, partners and members of the wider life sciences community to join us in honouring and celebrating the life of our late CEO, Dr Sally Ann Forsyth OBE DSc, at a memorial gathering taking place at 3pm on Wednesday 1 July in the SBC Atrium.
GDES2026 is the premier international virtual conference for leading endocrinologists, diabetologists, and metabolic researchers from around the globe. Taking place on July 02-03, 2026, this congress is a vital platform for the dissemination of cutting-edge endocrine research and diabetes treatment strategies.
What’s Next for Translational Research?
Are you ready to challenge the status quo in drug development? Join industry pioneers at ARC Oxford on July 2 for the Creative Disruption Forum. Hosted by Prof Tony Sedgwick and Graham Combe, this high-energy event is designed to break down the traditional silos separating discovery from clinical execution. Through engaging keynote interviews and collaborative afternoon workshops, we will tackle the skyrocketing complexities of new modalities and modern therapeutics. If you are a biotech leader, investor, or R&D director eager to accelerate discoveries from the bench straight to the patient, this is your sandbox. Don't just follow the future—disrupt it.
The Milner Institute's annual showcase highlights promising Pre-Series A companies from our bio-incubator, local accelerators, as well as other selected national and international companies.
